Chargement en cours...
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature
The overall survival for patients with advanced papillary renal carcinoma (RCC) is still limited. Although multikinase inhibitors have recently been developed for clear cell carcinoma, response rates in other histology non-clear cell RCC are poor and patients often face dose-limiting toxicities whic...
Enregistré dans:
| Publié dans: | Can Urol Assoc J |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Canadian Medical Association
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455657/ https://ncbi.nlm.nih.gov/pubmed/26085897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2264 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|